Moneycontrol
HomeNewsBusinessCoronavirus pandemic | Demand for credit cards, personal loans to go up, so will stress in these segments: Report  
Trending Topics

Coronavirus pandemic | Demand for credit cards, personal loans to go up, so will stress in these segments: Report  

Banks should redesign their mix of secured and unsecured lending to take care of their assets, TransUnion Cibil has said.

June 11, 2020 / 15:06 IST
Story continues below Advertisement

Demand for credit cards and personal loans is likely to rise with consumers looking for ways to bridge their payment obligations and cash flow problems, TransUnion Cibil has said, assessing the impact of the coronavirus outbreak on the reatil lending market.

There will be a sharp fall in discretionary spending as consumer sentiment will be negative and many companies will see their revenues fall, the credit information and insights company said in a report released on June 10.

Story continues below Advertisement

“Despite the Indian government launching one of the largest economic relief packages in the world, the social, financial and economic impact of COVID-19 will be far-reaching and will lead to a realignment of the retail credit market,” said Abhay Kelkar, vice president of research and consulting for TransUnion Cibil.

The report warns of stress building up in the personal loan and credit card segment. Banks should redesign their mix of secured and unsecured lending to take care of their assets, says the report titled Retail Credit Outlook, Anticipating and Preparing for the Covid19 Impact on the Retail Credit Market.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show